1,376
Views
26
CrossRef citations to date
0
Altmetric
Editorial

Preparing multiple-reaction monitoring for quantitative clinical proteomics

&
Pages 225-229 | Published online: 09 Jan 2014

Figures & data

Figure 1. Multiple-reaction monitoring (MRM) applied to early cancer diagnosis.

One MRM run per patient blood sample can measure many cancer biomarkers at the same time. MRM assays use less than 20 µl of blood.

AFP: α-fetoprotein; BTA: Bladder tumor antigen; CEA: Carcinoembryonic antigen; NSE: Neuron-specific enolase; PSA: Prostate-specific antigen.

Figure 1. Multiple-reaction monitoring (MRM) applied to early cancer diagnosis.One MRM run per patient blood sample can measure many cancer biomarkers at the same time. MRM assays use less than 20 µl of blood.AFP: α-fetoprotein; BTA: Bladder tumor antigen; CEA: Carcinoembryonic antigen; NSE: Neuron-specific enolase; PSA: Prostate-specific antigen.
Figure 2. Effect of drug treatment, modeled as the flux of targeted proteins in blood.

MRM: Multiple-reaction monitoring.

Figure 2. Effect of drug treatment, modeled as the flux of targeted proteins in blood.MRM: Multiple-reaction monitoring.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.